Cargando…

No beneficial effects of aspirin on secondary cardiovascular prevention in patients with type 2 diabetes using non‐steroidal anti‐inflammatory drugs

There is little evidence on whether non‐steroidal anti‐inflammatory drugs (NSAIDs) and aspirin interact in secondary cardiovascular prevention in type 2 diabetic patients. This is an observational study using data from the Action to Control Cardiovascular Risk in Diabetes and Follow‐on studies. Haza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujimoto, Tetsuro, Kajio, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767776/ https://www.ncbi.nlm.nih.gov/pubmed/30941845 http://dx.doi.org/10.1111/dom.13737

Ejemplares similares

Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Intensive Blood Pressure Treatment for Resistant Hypertension: Secondary Analysis of a Randomized Controlled Trial
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018)

Aspirin and its related non-steroidal anti-inflammatory drugs
por: Mahdi, Eamon J.
Publicado: (2013)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Optimal cardiac strategy based on the history of myocardial infarction in type 2 diabetic patients with coronary artery disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019)

Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)

Favourable changes in mortality in people with diabetes: US NHANES 1999–2010
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes
por: Nakamura, Tomoka, et al.
Publicado: (2023)

Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Obesity, diabetes, and length of time in the United States: Analysis of National Health and Nutrition Examination Survey 1999 to 2012
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer
por: Wilson, J C, et al.
Publicado: (2013)

Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients
por: Sossdorf, Maik, et al.
Publicado: (2013)

Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

High risk of renal dysfunction in patients with fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2017)

Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications
por: Tsujimoto, Tetsuro, et al.
Publicado: (2016)

Association between use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs and erectile dysfunction: A systematic review
por: Li, Tao, et al.
Publicado: (2018)

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer
por: Macfarlane, T V, et al.
Publicado: (2014)

Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis
por: Schwier, Nicholas, et al.
Publicado: (2016)

Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies
por: Zaman, Farzana Y., et al.
Publicado: (2022)

Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population‐based observational study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
por: Meek, Inger L., et al.
Publicado: (2010)

Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
por: Djatche, Laurence M., et al.
Publicado: (2018)

Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
por: Spartalis, Michael, et al.
Publicado: (2023)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark
por: Chang, E T, et al.
Publicado: (2011)

Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study
por: Walker, A J, et al.
Publicado: (2012)

Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec
por: Takahashi, Nobuyuki, et al.
Publicado: (2016)

Effectiveness of Prior Use of Beta-Blockers for Preventing Adverse Influences of Severe Hypoglycemia in Patients With Diabetes: An Observational Study
por: Tsujimoto, Tetsuro, et al.
Publicado: (2015)

Non-steroidal anti-inflammatory drugs and bladder cancer prevention
por: Castelao, J E, et al.
Publicado: (2000)

Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
por: Bello, Alfonso E., et al.
Publicado: (2014)

Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects
por: Pérez-Alzate, Diana, et al.
Publicado: (2016)

Dose-dependent roles of aspirin and other non-steroidal anti-inflammatory drugs in abnormal bone remodeling and skeletal regeneration
por: Xie, Yong, et al.
Publicado: (2019)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2007)

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
por: Trelle, Sven, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_30c532m5g2023vg2ub8uqsg8tc